Virginia Savova

机构：AstraZeneca (South Korea), AstraZeneca (Australia), AstraZeneca (Brazil) · ORCID：0000-0002-5387-4161

发表论文 92 篇 · 总被引 5807 次 · h-index 23

代表论文

• Estimating the impact of single-cell RNA sequencing of human tissues on drug target validation (2024 · medRxiv · 被引 23)
• Molecular Features and Stages of Pulmonary Fibrosis Driven by Type 2 Inflammation (2023 · American Journal of Respiratory Cell and Molecular Biology · 被引 23)
• Single-cell RNA profiling of blood CD4+ T cells identifies distinct helper and dysfunctional regulatory clusters in children with SLE (2025 · Nature Immunology · 被引 12)
• Scaling up single-cell RNA-seq data analysis with CellBridge workflow (2023 · Bioinformatics · 被引 11)
• An immunocompetent human kidney on-a-chip model to study renal inflammation and immune-mediated injury (2024 · Biofabrication · 被引 10)
• An agentic AI framework for ingestion and standardization of single-cell RNA-seq data analysis (2026 · npj Artificial Intelligence · 被引 9)